- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/06 - 1,2,3-TriazolesHydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
Patent holdings for IPC class C07D 249/06
Total number of patents in this class: 682
10-year publication summary
|
57
|
43
|
59
|
45
|
46
|
52
|
36
|
38
|
32
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4725 |
25 |
| Centre National de La Recherche Scientifique | 11010 |
16 |
| F. Hoffmann-La Roche AG | 7838 |
11 |
| Janssen Pharmaceutica N.V. | 3175 |
11 |
| Institut Curie | 615 |
10 |
| Universite de Montpellier | 1040 |
10 |
| The Regents of the University of California | 20694 |
9 |
| Bayer Cropscience AG | 1847 |
9 |
| Siemens Medical Solutions USA, Inc. | 1465 |
8 |
| Roche Diagnostics Operations, Inc. | 1517 |
7 |
| Imago Biosciences, Inc. | 39 |
7 |
| The University of Queensland | 663 |
7 |
| Sigilon Therapeutics, Inc. | 112 |
7 |
| E. I. du Pont de Nemours and Company | 3553 |
6 |
| Arcus Biosciences, Inc. | 164 |
6 |
| FMC Corporation | 808 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 178 |
6 |
| The Research Foundation for The State University of New York | 1731 |
6 |
| Yale University | 2528 |
6 |
| Pfizer Inc. | 3380 |
5 |
| Other owners | 504 |